151 related articles for article (PubMed ID: 33478441)
1. Lateral lymph node dissection for mid-to-low rectal cancer: is it safe and effective in a practice-based cohort?
Numata M; Tamagawa H; Kazama K; Kawahara S; Sawazaki S; Aoyama T; Maezawa Y; Kano K; Higuchi A; Godai T; Saigusa Y; Saeki H; Yukawa N; Rino Y
BMC Surg; 2021 Jan; 21(1):51. PubMed ID: 33478441
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer: A Subgroup Analysis of a Large Multicenter Cohort Study in Japan.
Yamaguchi T; Konishi T; Kinugasa Y; Yamamoto S; Akiyoshi T; Okamura R; Ito M; Nishimura Y; Shiozawa M; Yamaguchi S; Hida K; Sakai Y; Watanabe M
Dis Colon Rectum; 2017 Sep; 60(9):954-964. PubMed ID: 28796734
[TBL] [Abstract][Full Text] [Related]
3. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
4. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
[No Abstract] [Full Text] [Related]
5. Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis.
Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q;
Jpn J Clin Oncol; 2023 Jan; 53(1):26-34. PubMed ID: 36354102
[TBL] [Abstract][Full Text] [Related]
6. [Short-term efficacy of robotic-assisted total mesorectal excision with and without lateral lymph node dissection for mid-low advanced rectal cancer: a propensity score matching analysis].
Shi FY; Zhang L; Qin Q; Jin X; Hu CH; Yu TY; Ma L; Wang GH; Wu H; Xia P; Sun XJ; She JJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):370-376. PubMed ID: 32306605
[No Abstract] [Full Text] [Related]
7. Oncological outcomes of robotic-assisted laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer.
Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Furutani A; Manabe S; Yamaoka Y; Hino H
Surg Endosc; 2018 Nov; 32(11):4498-4505. PubMed ID: 29721748
[TBL] [Abstract][Full Text] [Related]
8. Effect of lateral lymph node dissection for mid and low rectal cancer: An ad-hoc analysis of the ACTS-RC (JFMC35-C1) randomized clinical trial.
Oki E; Shimokawa M; Ando K; Murata A; Takahashi T; Maeda K; Kusumoto T; Munemoto Y; Nakanishi R; Nakashima Y; Saeki H; Maehara Y
Surgery; 2019 Mar; 165(3):586-592. PubMed ID: 30314724
[TBL] [Abstract][Full Text] [Related]
9. [Feasibility of a three-sided encapsulation procedure based on fascia anatomy in laparoscopic lateral lymph node dissection for middle and low rectal cancer].
Li WJ; Diao DC; Lin JX; Wang JH; Liao WL; Tang X; Xie JX; Ao L; Zhang XY; Yi XJ; Feng XC; Li HM; Lu XQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):968-976. PubMed ID: 37849268
[No Abstract] [Full Text] [Related]
10. Is laparoscopic selective lateral lymph node dissection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy safe?
Yang X; Gu C; Hu T; Bi L; Wei M; Deng X; Wang Z; Zhou Z
ANZ J Surg; 2019 Nov; 89(11):E492-E497. PubMed ID: 31566296
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and safety of lateral pelvic lymph node dissection for elderly patients with middle-low rectal cancer: results of a large multicenter lateral node collaborative group study in China.
Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q
Tech Coloproctol; 2023 Aug; 27(8):655-664. PubMed ID: 36515808
[TBL] [Abstract][Full Text] [Related]
12. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term outcomes of laparoscopic versus open lateral lymph node dissection for locally advanced middle/lower rectal cancer using a propensity score-matched analysis.
Watanabe J; Ishibe A; Suwa Y; Ozawa M; Nakagawa K; Suwa H; Ota M; Kunisaki C; Endo I
Surg Endosc; 2021 Aug; 35(8):4427-4435. PubMed ID: 32875413
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term outcomes of laparoscopic versus open selective lateral pelvic lymph node dissection for locally advanced middle-low rectal cancer: Results of a multicentre lateral node study in China.
Tang J; Zhou S; Zhao W; Lou Z; Liang J; Feng B; Yang Y; Wang X; Liu Q;
Colorectal Dis; 2022 Nov; 24(11):1325-1334. PubMed ID: 35713974
[TBL] [Abstract][Full Text] [Related]
15. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
[TBL] [Abstract][Full Text] [Related]
16. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
[TBL] [Abstract][Full Text] [Related]
17. Optimal Size Criteria for Lateral Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Kawai K; Shiratori H; Hata K; Nozawa H; Tanaka T; Nishikawa T; Murono K; Ishihara S
Dis Colon Rectum; 2021 Mar; 64(3):274-283. PubMed ID: 33395141
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic lateral pelvic lymph node dissection is achievable and offers advantages as a minimally invasive surgery over the open approach.
Nagayoshi K; Ueki T; Manabe T; Moriyama T; Yanai K; Oda Y; Tanaka M
Surg Endosc; 2016 May; 30(5):1938-47. PubMed ID: 26275538
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of indocyanine green fluorescence imaging-guided laparoscopic lateral pelvic lymph node dissection for clinical stage II/III middle-lower rectal cancer: a propensity score-matched cohort study.
Watanabe J; Ohya H; Sakai J; Suwa Y; Goto K; Nakagawa K; Ozawa M; Ishibe A; Suwa H; Kunisaki C; Endo I
Tech Coloproctol; 2023 Sep; 27(9):759-767. PubMed ID: 36773172
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
